[go: up one dir, main page]

WO2002050098A3 - Haplotypes du gene du recepteur de la prolactine (prlr) - Google Patents

Haplotypes du gene du recepteur de la prolactine (prlr) Download PDF

Info

Publication number
WO2002050098A3
WO2002050098A3 PCT/US2001/049049 US0149049W WO0250098A3 WO 2002050098 A3 WO2002050098 A3 WO 2002050098A3 US 0149049 W US0149049 W US 0149049W WO 0250098 A3 WO0250098 A3 WO 0250098A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
prlr
gene
disclosed
prlr gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/049049
Other languages
English (en)
Other versions
WO2002050098A2 (fr
Inventor
Karyn M Bieglecki
Amy Duda
Beena Koshy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Priority to AU2002229099A priority Critical patent/AU2002229099A1/en
Publication of WO2002050098A2 publication Critical patent/WO2002050098A2/fr
Publication of WO2002050098A3 publication Critical patent/WO2002050098A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne de nouveaux variants génétiques du gène du récepteur de la prolactine (PRLR). La présente invention concerne plusieurs génotypes, haplotypes et paires d'haplotypes existant dans la population des Etats-Unis pour le gène du récepteur de la prolactine. La présente invention concerne également des compositions et des méthodes d'haplotypage et/ou de génotypage du gène du récepteur de la prolactine chez un individu. L'invention concerne également des polynucléotides définis par les haplotypes décrits ci-dessus.
PCT/US2001/049049 2000-12-18 2001-12-18 Haplotypes du gene du recepteur de la prolactine (prlr) Ceased WO2002050098A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002229099A AU2002229099A1 (en) 2000-12-18 2001-12-18 Haplotypes of the prlr gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25652300P 2000-12-18 2000-12-18
US60/256,523 2000-12-18

Publications (2)

Publication Number Publication Date
WO2002050098A2 WO2002050098A2 (fr) 2002-06-27
WO2002050098A3 true WO2002050098A3 (fr) 2003-03-20

Family

ID=22972544

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/049049 Ceased WO2002050098A2 (fr) 2000-12-18 2001-12-18 Haplotypes du gene du recepteur de la prolactine (prlr)

Country Status (2)

Country Link
AU (1) AU2002229099A1 (fr)
WO (1) WO2002050098A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008535853A (ja) * 2005-04-07 2008-09-04 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド 癌関連遺伝子
EP2129793A1 (fr) * 2007-03-20 2009-12-09 Institut National De La Sante Et De La Recherche Medicale Mutants constitutivement actifs du recepteur de la prolactine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GLASOW ET AL.: "Mutational analysis of the PRL receptor gene in human breast tumors with differential PRL receptor protein expression", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 86, no. 8, August 2001 (2001-08-01), pages 3826 - 3832, XP002958195 *
HU ET AL.: "The human prolactin receptor gene structure and alternative promoter utilization: the generic promoter hPIII and a novel human promoter hPN", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 84, no. 3, March 1999 (1999-03-01), pages 1153 - 1156, XP002958196 *
NICKERSON ET AL.: "Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene", GENOME RESEARCH, vol. 10, no. 10, October 2000 (2000-10-01), pages 1532 - 1545, XP002947337 *

Also Published As

Publication number Publication date
AU2002229099A1 (en) 2002-07-01
WO2002050098A2 (fr) 2002-06-27

Similar Documents

Publication Publication Date Title
WO2001090122A3 (fr) Haplotypes du gene ctla4
WO2002006294A3 (fr) Haplotypes du gene mmp13
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002018414A3 (fr) Haplotypes du gène bf
WO2002026764A3 (fr) Haplotypes du gene ccr6
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2001087904A3 (fr) Haplotypes du gene gpr4
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2002032924A3 (fr) Haplotypes du gene chrm5
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2002026770A3 (fr) Haplotypes du gene admr
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2002044201A3 (fr) Haplotypes du gene sah
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2001085742A3 (fr) Haplotypes du gene npy1r
WO2002038587A3 (fr) Haplotypes du gene grm8
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2002036609A3 (fr) Haplotypes du gene chrm4
WO2001087908A3 (fr) Haplotypes du gene ccr3

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP